Page last updated: 2024-08-24

rhodamine 110 and platinum

rhodamine 110 has been researched along with platinum in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ang, WH; Chin, CF; Ho, HK; Li, J; Pastorin, G; Venkatesan, T; Wong, BS; Yoong, SL; Yu, V; Zhou, QL	1

Other Studies

1 other study(ies) available for rhodamine 110 and platinum

Article	Year
Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin. Biomaterials, 2014, Volume: 35, Issue:2 Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Drug Delivery Systems; Drug Synergism; Flow Cytometry; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Microscopy, Confocal; Microscopy, Electron, Transmission; Mitochondria; Nanotubes, Carbon; Platinum; Prodrugs; Pyruvates; Rhodamines	2014

Article

Year

Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin.

Biomaterials, 2014, Volume: 35, Issue:2

Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Drug Delivery Systems; Drug Synergism; Flow Cytometry; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Microscopy, Confocal; Microscopy, Electron, Transmission; Mitochondria; Nanotubes, Carbon; Platinum; Prodrugs; Pyruvates; Rhodamines

2014